https://www.singlecare.com/blog/news/lutathera-digestive-tract-cancers/
FDA approves Lutathera for digestive tract cancers
Jul 17, 2020 - The FDA approved Lutathera to treat digestive tract cancers. Most common in the pancreas, these tumors can occur in the stomach, intestines, and rectum.
digestive tractfdaapproveslutatheracancers
https://www.medicines.org.uk/emc/product/12723/smpc/print
Lutathera 370 MBq/mL solution for infusion - Summary of Product Characteristics (SmPC) - print...
Lutathera 370 MBq/mL solution for infusion - Summary of Product Characteristics (SmPC) by Novartis Pharmaceuticals UK Ltd - print friendly
https://www.medicines.org.uk/emc/product/12723/rmms
Lutathera 370 MBq/mL solution for infusion - Risk Management Materials - (emc) | 12723
Lutathera 370 MBq/mL solution for infusion - Risk Management Materials by Novartis Pharmaceuticals UK Ltd